1. Home
  2. NATH vs MYGN Comparison

NATH vs MYGN Comparison

Compare NATH & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$101.52

Market Cap

412.2M

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.26

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATH
MYGN
Founded
1916
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
412.2M
444.2M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NATH
MYGN
Price
$101.52
$4.26
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$7.64
AVG Volume (30 Days)
17.7K
1.4M
Earning Date
06-09-2026
05-05-2026
Dividend Yield
1.99%
N/A
EPS Growth
22.29
N/A
EPS
4.17
N/A
Revenue
$104,201,000.00
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
$24.35
N/A
Revenue Growth
7.81
2.33
52 Week Low
$88.67
$3.75
52 Week High
$118.32
$8.59

Technical Indicators

Market Signals
Indicator
NATH
MYGN
Relative Strength Index (RSI) 59.83 40.30
Support Level $100.25 $3.76
Resistance Level $102.07 $5.30
Average True Range (ATR) 0.42 0.29
MACD 0.05 -0.08
Stochastic Oscillator 90.10 33.65

Price Performance

Historical Comparison
NATH
MYGN

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: